Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. www.nhs.uk › conditions › beta-blockersBeta blockers - NHS

    Beta blockers may be used to treat: angina – chest pain caused by narrowing of the arteries supplying the heart. heart failure – failure of the heart to pump enough blood around the body. atrial fibrillation – irregular heartbeat. heart attack – an emergency where the blood supply to the heart is suddenly blocked.

  2. 16 paź 2021 · Identifying distinct clusters of patients, including in sinus rhythm with a lack of treatment response and in atrial fibrillation with significant mortality benefit from β blockers, this study provides a novel method to better classify patients with heart failure.

  3. Beta-blockers are now a worldwide mainstay of heart failure treatment recommended in all international guidelines for chronic heart failure: this is a reversal of previous practice since they were completely contraindicated in this condition up to the late 1990s.

  4. 5 maj 2020 · Grants and funding. CDF-2015-08-074/DH_/Department of Health/United Kingdom. BHF_/British Heart Foundation/United Kingdom. Beta-blockers substantially reduce mortality in HF patients in sinus rhythm, but for other conditions, clinicians need to weigh up both benefit and potential risk.

  5. Beta blockers are now recommended in all international guidelines for the treatment of chronic heart failure. Thanks to BHF research, all these groups of drugs are now a vital part of heart failure treatment in the UK and worldwide. First published 1st June 2021.

  6. www.nhsinform.scot › medicines-and-medical-aids › types-of-medicineBeta-blockers - NHS inform

    31 maj 2024 · Beta-blockers (beta-adrenoceptor blocking agents) work mainly by decreasing the activity of the heart. They do this by blocking the action of hormones like adrenaline. What are beta-blockers used for? Beta-blockers may be used to treat: angina; heart failure; atrial fibrillation; heart attack; high blood pressure

  7. 16 paź 2021 · Interpretation: An artificial intelligence-based clustering approach was able to distinguish prognostic response from β blockers in patients with heart failure and reduced LVEF. This included patients in sinus rhythm with suboptimal efficacy, as well as a cluster of patients with atrial fibrillation where β blockers did reduce mortality.

  1. Ludzie szukają również